IGF1 and metabolic dysfunction-associated steatohepatitis: IGF-1 administration in mouse models with methionine-choline-deficient diet-induced nonalcoholic steatohepatitis and dimethylnitrosamine-induced cirrhosis ameliorated hepatic steatosis, inflammation, and fibrosis (25).